Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a092b731774e387720fba9260968b7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3aac60acd239ef06288b43035241dc83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9885a156bbe5917890912b40d3de8a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78df8864c817a0731fc96ab10de8186a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-17022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-6054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7115 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2008-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b84591d0dbdd1215302fb1f6760abcb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be01b028b85f61fc7373937ce90fe085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcb640945e8db0e397006188144b8815 |
publicationDate |
2012-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8309071-B2 |
titleOfInvention |
Foamy viral envelope genes |
abstract |
The present invention concerns the technical field of nucleic acids and expression-optimized nucleic acids. The present invention concerns especially nucleic acids comprising a mutated foamy viral envelope gene encoding a foamy viral envelope polypeptide, which comprises a leader peptide (LP), a surface unit (SU) and a transmembrane domain (TM). The present invention also relates to modified polypeptides encoded by these nucleic acids. Furthermore, the present invention regards a method for preparing pseudotyped vector particles as well as a method for treating a genetic disorder comprising administering a nucleic acid or a polypeptide encoded by that nucleic acid. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012141440-A1 |
priorityDate |
2008-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |